Cardiovascular Week articles from March 2004

Cardiovascular Week archives from March 2004

Hsp70 protects against cerebral ischemia through many mechanisms.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Hsp70 protects against cerebral ischemia through many mechanisms. "Overexpression of inducible Hsp70 has been shown to provide protection from cerebral ischemia both in animal models of stroke and...

Angiotensin II type 1a receptor marks pregnancy-associated hypertension.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Angiotensin II type 1a receptor marks pregnancy-associated hypertension. According to published research from Japan, "little is known about an in vivo significance of angiotensin II type-1 receptor...

Hand-held echocardiography devices feasible for LVH testing.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Hand-held echocardiography devices are suitable for use in community-based LVH screening. "Left ventricular (LV) hypertrophy (LVH) confers increased cardiovascular risk on patients with...

Role of mineralocorticoid receptor antagonists for heart failure reviewed.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A researcher has reviewed the role of mineralocorticoid receptor antagonists in the treatment of cardiac failure in a recent issue of Expert Opinion on Investigational Drugs. "In most countries,...

Depression may be a risk factor for heart disease, death in older women.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Older women with symptoms of depression may be at an increased risk of heart disease and death, researchers suggest. Previous studies report that depressive symptoms, including sub-threshold...

Three-year data highlight Viread efficacy, safety, and side effect profile.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Gilead Sciences, Inc., (GILD) announced preliminary 3-year (144-week) data from a double-blind, phase III clinical trial (Study 903) suggesting that Viread (tenofovir disoproxil fumarate) is associated...

Unnecessary hospital stay after heart attack common in European countries.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Despite a decade of research suggesting that low-risk patients can be discharged from the hospital after 4 days, many countries - especially in Europe - could be keeping patients in hospital for an...

Atorvastatin causes asymptomatic elevations of liver enzyme levels.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Atorvastatin causes asymptomatic elevations of liver enzyme levels. "The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (also known as statins) are associated with elevated transaminase...

Germline transfection is possible after intramyocardial gene delivery.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Germline transfection is possible after intramyocardial gene delivery. According to published research from the United States, "intramyocardial injection of adeno-associated virus (AAV) has been...

Data presented demonstrate enduring benefits of TMR.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), provider of angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Revascularization (PMR), announced that new, conclusive 5-year data...

Popular drug for chest pain may promote blood vessel damage.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Nitroglycerin, a drug commonly prescribed for the treatment of chest pain in patients with heart conditions, has the frustrating property that its beneficial effects are short-lived. Now, new...

Mechanisms of testosterone-induced coronary artery relaxation clarified.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The mechanisms of testosterone-induced coronary artery relaxation have been clarified. "The relationship between the level of testosterone and the incidence of coronary heart disease is still...

Interactions between ibuprofen and lipoproteins in blood plasma discovered.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Researchers have found evidence of interactions between ibuprofen and lipoproteins in human blood plasma using [superscript]1H NMR spectroscopy. According to published research from China, "Recent...

Monocyte-derived superoxide anions contribute to atherosclerosis.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Monocyte-derived superoxide anions contribute to atherosclerotic lesion formation. According to a study from the United States, "Monocyte extravasation into the vessel wall has been shown to be a...

Risk of heart attack and stroke tied to inflammation gene.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Kari Stefansson and colleagues at deCODE Genetics, Reykjavik, Iceland, have reported the identification of the first gene associated with a higher risk of both heart attacks and strokes, the diseases...

PA health department study shows 18% of 8th graders overweight.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Pennsylvania Health Secretary Dr. Calvin B. Johnson announced that 18% of the eighth graders who were studied in a recent assessment were overweight and another 17% are at risk of being overweight. ...

Cialis maker reports results for 2003.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- ICOS Corp. (ICOS) summarized 2003 highlights, released its financial results for the year and fourth quarter ended December 31, 2003, and provided guidance regarding financial performance expectations...

Pharmaceutical company announces dismissal of all lawsuits.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Titan Pharmaceuticals, Inc. (TTP) announced that all of the class action and derivative lawsuits filed against the company have been dismissed without prejudice. In every case, the plaintiffs...

ISOL myocyte apoptosis screening leads to fewer false-positive results.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- ISOL screening for myocyte apoptosis leads to fewer false-positive results than ISEL or TUNEL testing. In a recent study, scientists in Italy "assessed the efficiency of detecting myocyte apoptosis...

Medium perfusion enables functional cardiac tissue engineering.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Medium perfusion enables the engineering of functional cardiac tissue. Scientists in the United States "hypothesized that functional constructs with physiological cell densities can be engineered in...

The nitric oxide synthase pathway could be co-opted for angiogenic regulation.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The nitric oxide synthase pathway could be co-opted for angiogenic regulation. "Angiogenesis requires the elaboration of endothelium-derived nitric oxide (NO). Angiogenic factors induce the release...

The pyridoxine 5'-phosphate oxidase gene may be linked to hypertension.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The pyridoxine 5'-phosphate oxidase gene may be linked to hypertension. According to a study from Japan, "to identify candidate genes responsible for hypertension in Dahl salt-sensitive rats...

Transcatheter repair of traumatic ventricular septal defect reported.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Successful transcatheter-based repair of extensive ventrical septal trauma has been reported. Cardiologists in the United States reported "the first successful transcatheter closure of a large...

Calcineurin protects against ischemia-induced myocardial apoptosis.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Calcineurin signaling protects against ischemia-induced myocardial apoptosis. "Cardiovascular disease is the leading cause of mortality and morbidity within the industrialized nations of the world,...

Familial aggregation of left-sided obstructive heart defects confirmed.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Significant familial aggregation has been observed for a number of left-sided obstructive heart defects. "Cardiovascular malformations (CVM) are the most common birth defects and carry significant...

Hostility and anxiety differentially predict CVD in men and women.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Hostility and anxiety differentially predict CVD in men and women. "Consideration of the psychosocial contributions to cardiovascular disease (CVD) remains an ongoing focus of research in the...

Hyperhomocysteinemia activates endothelial cell NF-kappaB via oxidative stress.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Hyperhomocysteinemia activates NF-kappaB in endothelial cells through oxidative stress. According to recent research from Canada, "Hyperhomocysteinemia is an independent risk factor for...

Immersion achieves the second of three milestones in deal with Medtronic.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Immersion Corp. (IMMR), a developer and licensor of touch feedback technology, announced the achievement of the second of three significant milestones under development and licensing agreements with...

Murine ACE gene mutations influence cardiac fibrosis development.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Mutations in the ACE gene significantly influence the extent of myocardial fibrosis in rats. "In humans, the effect of angiotensin-converting enzyme (ACE) gene polymorphisms in cardiovascular...

NAD(P)H oxidase inhibitor prevents aldosterone-induced hypertension.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- An NAD(P)H oxidase inhibitor prevents aldosterone-induced hypertension and cardiac hypertrophy in a murine model. According to a study from South Korea, heightened "bioavailability of reactive...

PET can elucidate regional sympathetic function during heart disease.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Positron emission topography (PET) imaging can be used to elucidate the effects of heart disease on regional sympathetic function. In a study from the United States, PET "was used to measure global...

Regurgitant valvular heart disease risk elevated in acromegaly.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The risk of regurgitant valvular heart disease is elevated in acromegaly patients. "Cardiac involvement is common in acromegaly, but the prevalence of valvular abnormalities in patients with...

Dosing complete for phase II clinical trial on FM-VP4.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Forbes Medi-Tech, Inc., (FMTI) announced that dosing of subjects has been completed for the phase II clinical trial of its cholesterol-lowering pharmaceutical, FM-VP4. The phase II trial to measure...

Clerodendron colebrookianum Walp has cardioprotective effects.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The cardioprotective efficacy of a traditional Indian medicine has been confirmed. "Clerodendron colebrookianum Walp (family, Verbenaceae) has been used as a home remedy by the Mizo people of north...

PEECH trial reaches enrollment target.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Vasomedical, Inc., (VASO) announced that the patient enrollment target has been met in the PEECH (Prospective Evaluation of EECP in Congestive Heart Failure) trial, the company's pivotal clinical trial...

Promising target for treatment developed.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Jeffrey Molkentin and colleagues report a new strategy to treat heart disease by inhibiting the enzyme protein kinase C-alpha (PKC-alpha). PKC-alpha is expressed at higher levels in heart failure...

Acute coronary syndrome follows use of the symmetry bypass connector device.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Placement of the Symmetry Bypass Connector (St. Jude Medical, St. Paul, Minnesota) resulted in acute coronary syndrome and occluded saphenous vein grafts necessitating additional procedures in 5 of 121...

Study of adult stem cell reimplantation initiated.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- By harvesting and reimplanting a patient's own stem cells, physicians hope to grow new blood vessels to relieve the disabling chest pain of severely ill cardiac patients. Physicians at Caritas St....

Polyphenol concentrate isolated from red wine.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A novel polyphenol concentrate has been isolated from red wine and characterized. "Moderate consumption of red wine is associated with a decreased risk for coronary heart disease. Apart from...

von Willebrand factor mutation linked to increased CHD risk.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A von Willebrand factor gene mutation has been linked to a heightened risk of CHD in atherosclerosis patients. "The von Willebrand factor (VWF) may be causally associated with coronary heart...

Repaired sensing leads are as durable as new leads.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Researchers find that repairing broken implantable defibrillator leads with a patch kit is as durable as replacing the leads and may reduce morbidity and hospital stay. "Breaks in the insulation...

Researchers - again - pinpoint why stress kills.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- One prevailing argument for marriage may well be that studies show married people are less depressed than their single counterparts. Behind this string of scientific reasoning for matrimony is a...

Electrocardiogram abnormalities could be potentially deadly sign for diabetics.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Diabetics who have certain abnormalities on an electrocardiogram (ECG) are much more likely to die in a 5-year period than their peers who have normal ECG results, New York-Presbyterian Hospital/Weill...

Optimal care of type 2 diabetic patients with heart disease outlined.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A clinician from the Mayo Clinic outlines the optimal care of patients with type 2 diabetes and coronary artery disease in a recent issue of the American Journal of Medicine. "Although...

Human BioSystems signs exclusive sales agreement for MyoVision line.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Human BioSystems (HBSC), a biomedical company conducting research to extend the shelf life of blood platelets and donor organs, announced that it has signed an exclusive sales consulting agreement with...

Americans urged to curb their taste for salt.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Americans eat more than twice the salt they should but don't get enough potassium, an imbalance that fuels high blood pressure. So says long-awaited nutrition report, released February 11, 2004, by...

Diet guru Atkins' medical records spark another round in diet fight.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The debate over Robert Atkins, MD's, popular high-fat, low-carbohydrate diet flared posthumously February 10, 2004, when it was learned that Atkins himself was a bloated 258 pounds (116 kilograms) at...

Effects of high-sodium diet on oxidative stress in aorta clarified.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The effects of a high-sodium diet on oxidative stress in the aorta have been characterized. In a recent study from the United States, "Sprague-Dawley rats were fed either a high-salt (HS) diet...

Public health intervention needed to reduce U.S. dietary sodium intake?
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Is a public health intervention needed to reduce dietary sodium intake in the United States? "Elevated blood pressure levels are a major cause of heart disease and stroke," scientists there...

Cedrelopsis grevei has antihypertensive effects.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Cedrelopsis grevei has significant antihypertensive effects in a murine model. Scientists in France conducted a study "to investigate the cardiovascular consequences of oral administration of...

Nolomirole attenuates monocrotaline-induced heart failure.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Nolomirole attenuates monocrotaline-induced heart failure in rats. "Neurohormonal activation has been shown to be a major factor in congestive heart failure progression and mortality," scientists...

Allograft implant processor announces 2003 financial results.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Regeneration Technologies, Inc., (RTI) the Florida-based processor of orthopedic, cardiovascular and other allograft implants, announced that the company's net revenues were $75.5 million for the full...

MedCath Corp. reports first quarter earnings.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- MedCath Corp., a national provider of cardiovascular services, announced its operating results for its first quarter ended December 31, 2003. MedCath's net revenue increased 29.3% to $156.6 million...

Therapeutics company announces completion of private placement.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Valentis, Inc. (VLTS) announced the completion of the sale of the remaining shares from the maximum allocation in its private placement, of which the company raised a total of $10 million in a private...

Minnesota Heart Failure Consortium launches study of fluid-removal system.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- CHF Solutions, a private medical device manufacturer, announced that the Minnesota Heart Failure Consortium (MHFC), a nonprofit research organization based in Minneapolis, Minnesota, has launched a...

Company licenses patents to siRNA technology.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc., (NSTK), a drug-delivery technology company, announced that it has received a worldwide, nonexclusive license to the Fire et al. patents and patent applications titled...

Biotechnology and medical genomics partnership awards research grants.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Minnesota Governor Tim Pawlenty hosted officials from the Mayo Clinic and the University of Minnesota for the announcement of the first research grants awarded by the Minnesota Partnership for...

AHA issues new guidelines for preventing heart disease in women.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- The American Heart Association (AHA) recently announced new guidelines for the prevention of cardiovascular disease (CVD) in women. Published in the February 2004 issue of Circulation, an AHA...

Binodenoson phase II clinical data published.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) reported the online publication of the results of a phase II clinical trial involving binodenoson. The report is entitled "Randomized, Controlled Dose-Ranging Study...

Study: Lp-PLA2 predicts coronary heart disease.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A prospective, case cohort study of the atherosclerosis risk in communities (ARIC) population supports the measurement of lipoprotein-associated phospholipase A2 (Lp-PLA2) to help identify individuals...

Women still underestimating heart disease as greatest health risk.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A survey of 500 women ages 35 years and older residing in Orange and Los Angeles counties, California, shows that women still underestimate heart disease as their greatest health risk. Sponsored by...

FDA clearance granted for new cardiac imaging software.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Chase Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Simon, the company's innovative three-dimensional analysis system to be used by physicians to quickly and...

Moderate drinking associated with lower inflammation in elderly.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Seniors who consume one to seven alcoholic beverages a week tend to have lower blood levels of inflammatory markers than those who do not drink, according to a new report. The study is the first to...

CE Mark issued for Celacade chronic heart failure treatment.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Vasogen Inc. (VSGN) has been granted CE Mark regulatory approval in Europe for its lead product, Celacade (immune modulation therapy), for the treatment of chronic heart failure. This regulatory...

Elevated LVEDP may induce myocardial cytokine release.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Elevated LVEDP may induce myocardial cytokine release in heart failure patients. According to recent research from South Korea, "Proinflammatory cytokines and their receptors are increased in the...

Interstitial purine metabolites elevated during post-MI LV remodeling.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Interstitial purine metabolite levels are elevated in murine hearts with postinfarction LV remodeling. "The myocardial ATP concentration is significantly decreased in failing hearts, which may be...

Novel indices improve mechanical dyssynchrony evaluation.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A set of novel indices may improve mechanical dyssynchrony evaluation in heart failure patients. "Mechanical dyssynchrony is an important codeterminant of cardiac dysfunction in heart failure....

Redox modulation of inotropic response to dobutamine is impaired.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Redox modulation of the inotropic response to dobutamine is impaired in HF patients. According to published research from Canada, "It has been suggested that oxidative stress contributes to impaired...

U.S. clearance granted for AxSYM BNP test.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced that its manufacturing partner, Axis-Shield, has received clearance from the U.S. Food and Drug Administration for a B-type Natriuretic Peptide (BNP) test for use on...

Biventricular pacing may induce electrical remodeling.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Biventricular pacing therapy may induce electrical remodeling. According to recent research from New York, "Cardiac resynchronization therapy has been proven to improve symptoms and indices of left...

Crataegus extract WS(R) 1442 augments LVEF.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Crataegus extract WS(R) 1442 augments LVEF in heart failure patients. According to scientists in Germany, the "effect of crataegus extract WS(R) 1442 on left ventricular function in patients...

Transcatheter PDA occlusion safe, effective for infants.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Transcatheter PDA occlusion is safe and effective for most infants. "Transcatheter occlusion of patent ductus arteriosus (PDA) using Gianturco coils (GCs) has been performed for the past decade,"...

Central angiotensin II increases tyrosine hydroxylase production in rat adrenal medulla.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Central angiotensin II increases tyrosine hydroxylase biosynthesis in the murine adrenal medulla. According to recent research from the United States, "Angiotensin II acting centrally contributes...

FDA approves Caduet as dual therapy.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., said that it has received approval from the U.S. Food and Drug Administration (FDA) to market its dual therapy medicine Caduet (amlodipine besylate/atorvastatin calcium) for the...

Company receives patent for cardiac repair technology.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC) announced the issuance of U.S. patent no. 6,673,604, entitled "Muscle Cells and Their Use in Cardiac Repair," which covers transplantable skeletal myoblast compositions (muscle...

Pritikin diet appears to lower heart attack risk factors.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- University of California, Los Angeles (UCLA) scientists report that the Pritikin diet, low in fat and high in fruits, vegetables and whole grains, augmented with daily exercise, significantly reduced...

Report urges Americans to reduce sodium.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A long-awaited nutrition report calls for a major drop in how much salt Americans eat every day, even though the average person already consumes far more than is recommended. But don't worry about...

Fitness should be discussed, weight monitored, by U.S. doctors at every checkup.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- A new report recommends that U.S. doctors monitor patients' weight and order them to exercise to help prevent obesity-related illnesses such as heart disease and diabetes. The report, in the...

Fresh specimens reveal more about human chorionic vascular activity.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Fresh specimens reveal more about human chorionic vascular activity. According to new research from Spain, "the aim of the study was to determine whether 24 hours (h) of cold storage of samples,...

A steerable guidewire improves the cephalic vein insertion of a pacing lead.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Using a steerable hydrophilic guidewire (HGW) via the cephalic vein (CV) is safe and effective for insertion of a permanent pacing lead. According to recent research from Italy, "The CV should be...

Multiple pacemaker safety alerts should prompt a switch to a different maker.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Pacemaker malfunction alerts from the manufacturer required multiple replacement operations, researchers report. "This report describes the experience of a large pacemaker center during three...

Reoperations for pacemaker repairs are routine over the long-term.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Researchers find that over 20 years of pacemaker use, reoperations are necessary to exchange parts of the device, yet pacemakers remain reliable for patients. According to recent research published...

Fifth U.S. patent granted for small molecule program.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR) announced that it has been granted a patent for the company's small molecule program by the United States Patent and Trademark Office. U.S. Patent Number...

Biomedical company announces new member of board of directors.
March 1, 2004... 2004 MAR 1 - (NewsRx.com & NewsRx.net) -- Response Biomedical Corp. (RBM) announced the appointment of Stan Yakatan, chairman of U.S.-based Katan Associates International, to the company's board of directors. The company also announced...